Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
BioLineRx Ltd. (BLRX) had Debt to Capital Ratio of 0.12 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.29M |
|
$-3.03M |
|
$0.06M |
|
$0.23M |
|
$3.87M |
|
$-3.57M |
|
$-0.77M |
|
$-4.34M |
|
$-4.34M |
|
$-4.34M |
|
$-4.34M |
|
$-4.34M |
|
$-4.34M |
|
$-3.57M |
|
$-3.50M |
|
4.44M |
|
4.44M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$16.35M |
|
$0.13M |
|
$17.13M |
|
$33.48M |
|
$13.68M |
|
$2.22M |
|
$3.18M |
|
$16.86M |
|
$16.62M |
|
$0.29M |
|
$16.62M |
|
4.37M |
|
| Cash Flow Statement Financials | |
$-5.50M |
|
$9.05M |
|
$-2.32M |
|
$3.25M |
|
$4.63M |
|
$1.38M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.20 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.12 |
0.40 |
|
79.93% |
|
-1215.31% |
|
-1215.31% |
|
-- |
|
-1475.85% |
|
-1029.25% |
|
$-5.49M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.03 |
|
0.40 |
|
222.86 |
|
-26.11% |
|
-1491.06% |
|
-12.96% |
|
-23.03% |
|
$3.80 |
|
$-1.24 |
|
$-1.24 |
|